Literature DB >> 15003291

The effects of monobromobimane on neuronal cell death in the hippocampus after transient global cerebral ischemia in rats.

Tsutomu Abe1, Norio Takagi, Midori Nakano, Satoshi Takeo.   

Abstract

Calcium accumulation and free radical formation in the mitochondria are suggested to result in opening of the mitochondrial permeability transition pore that may be an initial step in neuronal cell death. The purpose of the present study was to determine whether monobromobimane (MBM) was a possible protective agent against neuronal cell death after transient global ischemia and the swelling of isolated hippocampal mitochondria. Infusion of MBM (1 or 3 microg) to cerebral ventricles 30 min before ischemia attenuated the expression of TUNEL-labeled cells and neuronal cell death in the hippocampal CA1 region at 72 h of reperfusion dose-dependently. Treatment with MBM inhibited an increase in caspase-3-like activity at 48 h of reperfusion in the hippocampus. MBM (30-300 microM) also inhibited an enhanced swelling rate induced by Ca2+ and phenylarsineoxide in the isolated hippocampal mitochondria. These results suggest that in vivo treatment with MBM may protect against neuronal cell death through inhibition of the mitochondrial swelling and caspase-3-dependent apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003291     DOI: 10.1016/j.neulet.2003.12.088

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction.

Authors:  Vaibhav Gaur; Anil Kumar
Journal:  Inflammopharmacology       Date:  2011-08       Impact factor: 4.473

2.  Methodological Issue of Mitochondrial Isolation in Acute-Injury Rat Model: Asphyxia Cardiac Arrest and Resuscitation.

Authors:  Tomoaki Aoki; Yu Okuma; Lance B Becker; Kei Hayashida; Koichiro Shinozaki
Journal:  Front Med (Lausanne)       Date:  2021-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.